Abstract
Nanomedicine is a growing field with a great potential for introducing new generation of targeted and personalized drug. Amongst new generation of nano-vectors are carbon nanotubes (CNTs), which can be produced as single or multi-walled. Multi-walled carbon nanotubes (MWCNTs) can be fabricated as biocompatible nanostructures (cylindrical bulky tubes). These structures are currently under investigation for their application in nanomedicine as viable and safe nanovectors for gene and drug delivery. In this chapter, we will provide you with the necessary information to understand the synthesis of MWCNTs, functionalization, PKH26 labeling, RNAi, and DNA loading for in vitro experimentation and in vivo implantation of labeled MWCNT in mice as well as materials used in this experimentation. We used this technique to manipulate microglia as part of a novel application for the brain cancer immunotherapy. Our published data show this is a promising technique for labeling, and gene and drug delivery into microglia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Vittorio, O., Raffa, V., Cuschieri, A. (2009) Influence of purity and surface oxidation on cytotoxicity of multi-wall carbon nanotubes with human neuroblastoma cells. Nanomedicine: Nanotechnology, [Epub ahead of print; PMID: 19341817].
Liu, Z., Davis, C., Cai, W., He, L., Chen, X., Dai, H. (2008) Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci USA 105(5), 1410–1415.
Yehia, H. N., Draper, R. K., Mikoryak, C., Walker, E. K., Bajaj, P., Musselman, I. H., Daigrepont, M. C., Dieckmann, G. R., Pantano, P. (2007) Single-walled carbon nanotube interactions with HeLa cells. J Nanobiotechnology 5, 8.
Singh, R., Pantarotto, D., Lacerda, L., Pastorin, G., Klumpp, C., Prato, M., Bianco, A., Kostarelos, K. (2006) Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 103(9), 3357–3362.
Prato, M., Kostarelos, K., Bianco, A. (2008) Functionalized carbon nanotubes in drug design and discovery. Acc Chem Res 41(1), 60–68.
Kateb, B., Van Handel, M., Zhang, L., Bronikowski, M. J., Manohara, H., Badie, B. (2007) Internalization of MWCNTs by microglia: possible application in immunotherapy of brain tumors. Neuroimage, 37(1), S9–S17.
Poland, C. A., Duffin, R., Kinloch, I., Maynard, A., Wallace, W. A., Seaton, A., Stone, V., Brown, S., Macnee, W., Donaldson, K. (2008) Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nature Nanotech Nat Nanotechnol 3(7), 423–428.
Ding, L., Stilwell, J., Zhang, T., Elboudwarej, O., Jiang, H., Selegue, J. P., Cooke, P. A., Gray, J. W., Chen, F. F. (2005) Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast. Nano Lett 5(12), 2448–2464.
Podesta, J. E., Al-Jamal, K. T., Herrero, M. A., Tian, B., Ali-Boucetta, H., Hegde, V., Bianco, A., Prato, M., Kostarelos, K. (2009) Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a Human Lung Xenograft Model. Small [Epub ahead of print: PMID: 19306454].
Liu, Z., Chen, K., Davis, C., Sherlock, S., Cao, Q., Chen, X., Dai, H. (2008) Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 68(16), 6652–6660.
Bhirde, A. A., Patel, V., Gavard, J., Zhang, G., Sousa, A. A., Masedunskas, A., Leapman, R. D., Weigert, R., Gutkind, J. S., Rusling, J. F. (2009) Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 3(2), 307–316.
Hampel, S., Kunze, D., Haase, D., Krämer, K., Rauschenbach, M., Ritschel, M., Leonhardt, A., Thomas, J., Oswald, S., Hoffmann, V., Büchner, B. (2008) Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth. Nanomed 3(2): 175–182.
Villa, C. H., McDevitt MR, Escorcia, F. E., Rey, D. A., Bergkvist, M., Batt, C. A., Scheinberg, D. A. (2008) Synthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes. Nano Lett. 8(12):4221–4228.
Chen, J., Chen, S., Zhao, X., Kuznetsova, L. V., Wong, S. S., Ojima, I. (2008) Functionalized Single-Walled Carbon Nanotubes as Rationally Designed Vehicles for Tumor-Targeted Drug Delivery. J Am Chem Soc 130 (49), 16778–16785.
Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., Dai, H. (2007) In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2(1):47–52.
VanHandel M, Alizadeh, D., Zhang, L., Kateb, B., Bronikowski, M., Manohara, H., Badie, B. (2009) Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model. J Neuroimmunol 31, 208(1–2), 3–9.
Wen, P. Y., Kesari, S. (2008) Malignant gliomas in adults, N Engl J Med. 5:492-507.
Sehgal, A., Berger, M. S. (2000) Basic concepts of immunology and neuroimmunology. Neurosurg Focus 9(6).
Engelhardt, B. (2008) The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr Pharm Des 14(16), 1555–1565.
Stevens, A., Klöter, I., Roggendorf, W. (1988) Inflammatory infiltrates and natural killer cell presence in human brain tumors. Cancer 61(4), 738–743.
Streit, W. J., Conde, J. R., Fendrick, S. E., Flanary, B. E., Mariani, C. L. (2005) Role of microglia in the central nervous system’s immune response. Neurol Res 27(7), 685–691.
Tambuyzer, B.R., Ponsaerts, P., and Nouwen, E. J. (2009) Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol 85(3), 352–370.
Pollard, J. W. (2009) Trophic macrophages in development and disease. Nat Rev Immunol 9(4):259–270.
Chi, J. H., Panner, A., Cachola, K., Crane, C. A., Murray, J., Pieper, R. O., James, C. D., Parsa, A. T. (2008) Increased expression of the glioma-associated antigen ARF4L after loss of the tumor suppressor PTEN. Laboratory investigation. J Neurosurg 108(2), 299–303.
Hatano, M., Eguchi, J., Tatsumi, T., Kuwashima, N., Dusak, J. E., Kinch, M. S., Pollack, I. F., Hamilton, R. L., Storkus, W. J., Okada, H. (2005) EphA2 as a glioma-associated antigen: a novel target for glioma vaccines. Neoplasia 7(8), 717–722.
Mitchell, D. A., Fecci, P. E., Sampson, J. H. (2008) Immunotherapy of malignant brain tumors. Immunol Rev 222, 70–100.
Ueda, R., Iizuka, Y., Yoshida, K., Kawase, T., Kawakami, Y., Toda, M. (2004) Identification of a human glioma antigen, SOX6, recognized by patients’ sera. Oncogene 23(7):1420–1427
Parney, I. F., Farr-Jones, M. A., Chang, L. J., Petruk, K. C. (2000) Human glioma immunobiology in vitro: implications for immunogene therapy. Neurosurgery 46(5):1169–1177; discussion 1177–1178.
Takamura, Y., Ikeda, H., Kanaseki, T., Toyota, M., Tokino, T., Imai, K., Houkin, K., Sato, N. (2004) Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA) Glia 45(4), 392–405.
Galarneau, H., Villeneuve, J., Gowing, G., Julien, J. P., Vallières, L. (2007) Increased glioma growth in mice depleted of macrophages. Cancer Res 67(18):8874–8881.
Geranmayeh, F., Scheithauer, B. W., Spitzer, C., Meyer, F. B., Svensson-Engwall, A. C., Graeber, M. B. (2007) Microglia in gemistocytic astrocytomas. Neurosurgery 60(1), 159–66.
Graeber, M. B., Scheithauer, B. W., Kreutzberg, G. W. (2002) Microglia in brain tumors. Glia 40(2):252–259.
Watters, J. J., Schartner, J. M., Badie, B. (2005) Microglia function in brain tumors. J Neurosci Res 81(3), 447–455.
Manohara, H. M., Bronikowski, M. J., Hoenk, M., Hunt, B. D. and Siegel, P. H. (2006) High-current-density field emitters based on arrays of carbon nanotubes bundles, J Vac Sci Technol B 23(1), 157–161.
Bronikowski, M. J. (2006) CVD growth of carbon nanotube bundle arrays, Carbon, 44, 2822–2832.
Bronikowski, M. J., Manohara, H. M., and Hunt, B. D. (2006) Growth of carbon nanotube bundle arrays on silicon surfaces, J Vac Sci Technol, A 24(4) 1318–1322.
Acknowledgments
Part of the research described in this publication was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kateb, B. et al. (2010). Multi-walled Carbon Nanotube (MWCNT) Synthesis, Preparation, Labeling, and Functionalization. In: Yotnda, P. (eds) Immunotherapy of Cancer. Methods in Molecular Biology, vol 651. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-786-0_18
Download citation
DOI: https://doi.org/10.1007/978-1-60761-786-0_18
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-785-3
Online ISBN: 978-1-60761-786-0
eBook Packages: Springer Protocols